# Trade Mark Journal No.2025/026 27 June 2025

## WO0000001859194 (42,44)

Office of origin: United States of America

Date of International Registration:28 April 2025
Date of designation in the UK: 28 April 2025

International priority date claimed: 29 October 2024 (United States of America) (98825256)

Class 42
  Medical and scientific research and information services; scientific laboratory services; medical research laboratory services; biological research laboratory services; providing laboratory research services; genetic sequencing and molecular testing for scientific research purposes; molecular testing and services, namely, clinical diagnostics, scientific research, and processing and analysis of molecular assays; providing scientific research information; providing medical testing services and information in the field of disease research and classification.
Class 44
  Medical molecular testing, monitoring and reporting services; medical testing services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical laboratory analysis services; medical analysis services for diagnostic and treatment purposes; genetic sequencing and molecular testing for medical research, diagnostic and treatment purposes; providing information about molecular testing for medical purposes; consulting services in the fields of medical testing; medical diagnostic testing, monitoring and reporting services; medical diagnostic testing services in the field of human disease and human medical conditions; molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes.

Parse Biosciences, Inc.

Representative: Brendan J. Hughes Cooley LLP, 1299 Pennsylvania Avenue NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA